Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sharona Vaknin"'
Autor:
Arielle Kaim, Clara Singer, Lucia Bergovoy-Yellin, Osnat Luxenburg, Sharona Vaknin, Noga Boldor, Rachel Wilf-Miron, Vicki Myers
Publikováno v:
Israel Journal of Health Policy Research, Vol 13, Iss 1, Pp 1-6 (2024)
Abstract Background Medical imaging tests are vital in healthcare but can be costly, impacting national health expenditures. Magnetic resonance imaging (MRI) is a crucial diagnostic tool for assessing medical conditions. However, the rising demand fo
Externí odkaz:
https://doaj.org/article/c2666f1e00854b4e8ca7f9fc5d78893c
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundA clinical decision support system (CDSS), the European Society of Radiologists (ESR) iGuide, was developed to address gaps in the availability and use of effective imaging referral guidelines.AimThis study aimed to assess the appropriatene
Externí odkaz:
https://doaj.org/article/1da6a4de3ea14f6396303820aff68ea6
Autor:
Talya Markus, Mor Saban, Jacob Sosna, Jacob Assaf, Dotan Cohen, Sharona Vaknin, Osnat Luxenburg, Clara Singer, Dorith Shaham
Publikováno v:
Insights into Imaging, Vol 14, Iss 1, Pp 1-10 (2023)
Key points Inappropriate testing was prevalent. Experts agreement were increased after using the ESR iGuide. The use of the ESR iGuide may contribute to informed decision-making. The use of the ESR iGuide could increase uniformity among different exp
Externí odkaz:
https://doaj.org/article/663abd1b0a5d483dbb19f616eb9a3a80
Autor:
Noga Boldor, Sharona Vaknin, Vicki Myers, Nina Hakak, Michel Somekh, Rachel Wilf-Miron, Osnat Luxenburg
Publikováno v:
Israel Journal of Health Policy Research, Vol 10, Iss 1, Pp 1-8 (2021)
Abstract Background Long waiting times (WT) for Magnetic Resonance Imaging (MRI) are a challenge in many countries and demand is forecast to increase with ageing populations. Since MRI is essential for diagnosis in numerous medical conditions, timely
Externí odkaz:
https://doaj.org/article/56d9591b76cb40e5ad6e879e4546db1f
Publikováno v:
Israel Journal of Health Policy Research, Vol 10, Iss 1, Pp 1-10 (2021)
Abstract Background and purpose Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national a
Externí odkaz:
https://doaj.org/article/546b5ecb0ce546ccabad1cdf53c87261
Publikováno v:
Israel Journal of Health Policy Research, Vol 10, Iss 1, Pp 1-10 (2021)
Israel Journal of Health Policy Research
Israel Journal of Health Policy Research
Background and purpose Marked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and region
Autor:
Mor Saban, Jacob Sosna, Clara Singer, Sharona Vaknin, Vicki Myers, Dorit Shaham, Jacob Assaf, Alon Hershko, Paula Feder-Bubis, Rachel Wilf-Miron, Osnat Luxenburg
Publikováno v:
European radiologyReferences. 32(6)
To assess the acceptance and reliability of clinical decision support system (CDSS) imaging referral scores (ESR iGuide).A pilot study was conducted in a tertiary hospital. Four different experts were invited to rate 40 simulated clinical cases on a
Publikováno v:
Harefuah. 151(5)
Medical resonance imaging (MRI) is a technology for imaging and diagnosis of tissues and organs which does not use ionizing radiation. It was developed in the 1960's and 1970's and has been in clinical use since the 1980's. Over the last two decades
Publikováno v:
Harefuah. 150(1)
In the last two decades there has been a world wide increase in the number of drugs that are being switched from the prescription-only category to non-prescription categories. In Israel, until recently, non-prescription medicines were only permitted
Publikováno v:
Harefuah. 150(1)
The reformation in the marketing of non-prescription medicinal products has been launched. As of May 10th 2005, the pharmacist regulations 2004 (marketing of over-the-counter (OTC) drugs outside of pharmacies, as well as not by a pharmacist) will be